SLC29A1 Antilichaam
Gecertificeerd

SLC29A1 Antilichaam

Catalog #: 8125-01
Maat: 0.02 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

SLC29A1 is a member of the equilibrative nucleoside transporter family which plays a key role in nucleoside and nucleobase uptake for salvage pathways of nucleotide synthesis (1,2) . SLC29A1 is a transmembrane glycoprotein that localizes to the plasma and mitochondrial membranes and mediates the cellular uptake of nucleosides from the surrounding medium (3) . As a nucleoside transporter, SLC29A1 plays an important role in the uptake of nucleoside-based anti-cancer drugs; polymorphisms of point mutations in the gene encoding this protein may affect the efficacy of these drugs (4) .

NCBI Gene ID

2030

Swiss Prot

Q99808

Accession Number

NP_004946

Host

• Rabbit

Reactivity

Human

Clonality

• Polyclonal

Conjugation

Unconjugated

Type

Primary Antibodies

Field of Research

Cancer, Homeostasis

Purification

SLC29A1 antibody is affinity chromatography purified via peptide column.

Positive Control

Cat. No. 1316 - Human Ovary Tissue Lysate

Concentration

1 mg/mL

Homology

Predicted species reactivity based on immunogen sequence: Rat: (81%), Mouse: (75%)

Buffer

SLC29A1 antibody is supplied in PBS containing 0.02% sodium azide.

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

SLC29A1 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year.

Fragment

IgG

Specificity

SLC29A1 antibody is human specific. SLC29A1 antibody is predicted to not cross-react with other SLC29 proteins.

Symbol

SLC29A1

Positive Control 2

Cat. No. 11-201 - Human Ovary Tissue Slide

NCBI Official Name

Solute carrier family 29 (equilibrative nucleoside transporter), member 1

NCBI Organism

Homo sapiens

Background Reference 01

Griffiths M, Beaumont N, Yao SY, et al. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat. Med. 1997; 3:89-93.

Background Reference 02

Young JD, Yao SY, Baldwin JM, et al. The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29. Mol. Aspects. Med. 34:529-47.

Background Reference 03

Mangravite LM, Xiao G, and Giacomini KM. Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells. Am. J. Physiol. Renal Physiol. 284:F902-10.

Background Reference 04

Zimmerman EI, Huang M, Leisewitz AV, et al. Identification of a novel point mutation in ENT1 that confers resistance to Ara-C in human T cell leukemia CCRF-CEM cells. FEBS Lett. 2009; 583:425-9.

Other Product Names

Solute carrier family 29 member 1, Equilibrative nucleoside transporter 1, ENT1

Tested Applications

ELISA, WB, IHC-P, IF

Protein ID

4826716

Physical Properties

Liquid

Beschrijving

SLC29A1 Antilichaam Beschikbaar in 0.02 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamSLC29A1 Antilichaam
Categorie
Beschikbare grootte0.02 mg
Catalogusnummer8125-01